Sat, Sep 20, 2014, 6:03 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • terridiamond158 terridiamond158 Mar 6, 2013 11:44 AM Flag

    Leerink Raises CLDX to $18 A Day Before CLDX to Make Big Announcement. LINK

    Celldex Therapeutics (CLDX +2.3%) moves up after being initiated by Leerink Swann
    Seeking Alpha Market Currents
    · Wednesday, March 6, 11:11 AM ET
    Celldex Therapeutics (CLDX +2.3%) moves up after being initiated by Leerink Swann with an Outperform rating and a price target of $18 a share. Leerink cites the strength of the drug developer's portfolio, saying 6 wholly owned clinical-stage biologics assets make its breadth rare among small and mid-cap biotech companies. The coverage also comes just a day before the company is expected to announce plans for a late stage study of CDX-011, a treatment for metastatic breast cancer - which should be a key catalyst for the stock.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
14.05-0.04(-0.28%)Sep 19 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Novo Nordisk A/S
NYSEFri, Sep 19, 2014 4:02 PM EDT
Oracle Corporation
NYSEFri, Sep 19, 2014 4:00 PM EDT